DYNAMICS OF THE NUMBER OF SURGICAL AND ENDOVASCULAR OPERATIONS ON THE CORONARY ARTERIES FOR ISCHEMIC HEART DISEASE IN THE CONSTITUENT ENTITIES OF THE RUSSIAN FEDERATION (2014–2023). PART 2

Highlights

The regions of the Russian Federation differ significantly in the dynamics and ratio of the number of coronary artery bypass grafting and coronary artery angioplasty, which is associated not only with the indications for the use of these methods.

Absract

Aim. To assess the dynamics and variability of the number of myocardial revascularization operations for ischemic heart disease (IHD) in the constituent entities of the Russian Federation for 2014–2023; possibilities of modifying the accounting and analysis of data.

Methods. The data of Rosstat for 2014–2023 from the federal statistical observation form (FFSN) No. 14, table 2000 – information on the number of operations for ischemic heart disease performed in hospitals of the Russian Federation were used.

Results. An increase in the number of myocardial revascularization operations was revealed: (the average regional total number of coronary artery bypass grafting (CABG) operations plus angioplasty increased in 2023 compared to 2014 by 33.6 ± 27.5%). Regional variability in the number of CABG and angioplasty increased; their ratio in 2014 was 7.4 ± 2.2 and 38 ± 23 in 2023. Only in 21 regions more than 300 CABG surgeries were performed per year for all 10 years, of which 5 regions performed more than 1000. The COVID-19 pandemic has affected the volume of operations for coronary heart disease (compared to 2019, in 2020 the number of operations performed decreased in 60 regions, in 2021 compared to 2019 in 32 regions).

Conclusions. Regions differ significantly in the volume of revascularization surgeries and the ratio of myocardial revascularization types. FFSN does not allow assessing the causes of differences and ongoing changes; specialized studies are needed.

1. Moreno-Angarita, A., Peña, D., de León, J.D.LP. et al. Current indications and surgical strategies for myocardial revascularization in patients with left ventricular dysfunction: a scoping review. J Cardiothorac Surg 19, 469 (2024). https://doi.org/10.1186/s13019-024-02844-2

2. Alekyan B.G., Boytsov S.A., Manoshkina E.M., Ganyukov V.I. Myocardial revascularization in Russian Federation for acute coronary syndrome in 2016-2020. Kardiologiia. 2021;61(12):4-15. https://doi.org/10.18087/cardio.2021.12.n1879

3. Ivanov S.V., Sumin A.N. Current trends in routine myocardial revascularization. Complex Issues of Cardiovascular Diseases. 2021;10(2):25-35. (In Russ.) https://doi.org/10.17802/2306-1278-2021-10-2-25-35

4. Llerena-Velastegui J, Zumbana-Podaneva K, Velastegui-Zurita S, Mejia-Mora M, Perez-Tomassetti J, Cabrera-Cruz A, Haro-Arteaga P, de Jesus ACFS, Coelho PM, Sanahuja-Montiel C. Comparative Efficacy of Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in the Treatment of Ischemic Heart Disease: A Systematic Review and Meta-Analysis of Recent Randomized Controlled Trials. Cardiol Res. 2024 Jun;15(3):153-168. doi: 10.14740/cr1638.

5. Barbarash OL, Karpov YuA, Panov AV, et al. 2024 Clinical practice guidelines for Stable coronary artery disease. Russian Journal of Cardiology. 2024;29(9):6110. (In Russ.) https://doi.org/10.15829/1560-4071-2024-6110

6. 2020 Clinical practice guidelines for Acute ST-segment elevation myocardial infarction. Russian Journal of Cardiology. 2020;25(11):4103. (In Russ.) doi:10.15829/1560-4071-2020-4103

7. Cui K, Liu H, Yuan F, et al. Coronary artery bypass graft surgery versus stenting for patients with chronic kidney disease and complex coronary artery disease: a systematic review and meta-analysis. Therapeutic Advances in Chronic Disease. 2021;12. doi:10.1177/2040622321990273

8. Caldonazo, T., Kirov, H., Riedel, L.L. et al. Comparing CABG and PCI across the globe based on current regional registry evidence. Sci Rep 12, 22164 (2022). https://doi.org/10.1038/s41598-022-25853-4

9. Ten-year dynamics of surgical and endovascular treatment of ischemic heart disease in the Russian Federation (2014-2023). Part 1. Комплексные проблемы сердечно-сосудистых заболеваний. 2025 (принята к печати)

10. Barbarash O.L., Kashtalap V.V., Shibanova I.A., Kokov A.N. Fundamental and practical aspects of coronary artery calcification. Russian Journal of Cardiology. 2020;25(3S):4005. https://doi.org/10.15829/1560-4071-2020-4005

11. Nogueira-Garcia B, Vilela M, Oliveira C, Caldeira D, Martins AM, Nobre Menezes M. A Narrative Review of Revascularization in Chronic Coronary Syndrome/Disease: Concepts and Misconceptions. J Pers Med. 2024 May 10;14(5):506. doi: 10.3390/jpm14050506.

12. Patel KK, Peri-Okonny PA, Giorgetti A, Shaw LJ, Gimelli A. Value of Ischemia and Coronary Anatomy in Prognosis and Guiding Revascularization Among Patients With Stable Ischemic Heart Disease. Circ Cardiovasc Imaging. 2024 Sep;17(9):e016587. doi: 10.1161/CIRCIMAGING.123.016587.

13. Bangalore S, Rhodes G, Maron DJ, Anthopolos R, O'Brien SM, Jones PG, Mark DB, Reynolds HR, Spertus JA, Stone GW, White HD, Xu Y, Fremes SE, Hochman JS, Ischemia Research Group OBOT. Outcomes with revascularisation versus conservative management of participants with 3-vessel coronary artery disease in the ISCHEMIA trial. EuroIntervention. 2024 Oct 21;20(20):e1276-e1287. doi: 10.4244/EIJ-D-24-00240.

14. Timmis A, Aboyans V, Vardas P, Townsend N, Torbica A, Kavousi M, Boriani G, Huculeci R, Kazakiewicz D, Scherr D, Karagiannidis E, Cvijic M, Kapłon-Cieślicka A, Ignatiuk B, Raatikainen P, De Smedt D, Wood A, Dudek D, Van Belle E, Weidinger F; ESC National Cardiac Societies. European Society of Cardiology: the 2023 Atlas of Cardiovascular Disease Statistics. Eur Heart J. 2024 Oct 7;45(38):4019-4062. doi: 10.1093/eurheartj/ehae466.

15. Kumsa NB, Kelly TL, Roughead EE, Tavella R, Gillam MH. Temporal trends in percutaneous coronary intervention in Australia: A retrospective analysis from 2000-2021. Hellenic J Cardiol. 2024 Nov-Dec;80:21-30. doi: 10.1016/j.hjc.2023.10.002

16. Tam DY, Qiu F, Manoragavan R, Fremes SE, Hassan A, Ko DT, Lauck SB, Naimark D, Ouzounian M, Sander B, Sun L, Wijeysundera HC. The Impact of the COVID-19 Pandemic on Cardiac Procedure Wait List Mortality in Ontario, Canada. Can J Cardiol. 2021 Oct;37(10):1547-1554. doi: 10.1016/j.cjca.2021.05.008.

17. Aranda-Michel E, Serna-Gallegos D, Arnaoutakis G, Kilic A, Brown JA, Dai Y, Dunn-Lewis C, Sultan I. The Effect of COVID-19 on Cardiac Surgical Volume and its Associated Costs. Semin Thorac Cardiovasc Surg. 2023 Autumn;35(3):508-515. doi: 10.1053/j.semtcvs.2022.01.009.

18. Ivert T, Dalén M, Friberg Ö. Effect of COVID-19 on cardiac surgery volumes in Sweden. Scand Cardiovasc J. 2023 Dec;57(1):2166102. doi: 10.1080/14017431.2023.2166102.

19. Goicolea Ruigómez FJ, Elola FJ, Durante-López A, Fernández Pérez C, Bernal JL, Macaya C. Coronary artery bypass grafting in Spain. Influence of procedural volume on outcomes. Rev Esp Cardiol (Engl Ed). 2020 Jun;73(6):488-494. English, Spanish. doi: 10.1016/j.rec.2019.08.016

20. Jones DA, Gallagher S, Rathod K, Jain AK, Mathur A, Uppal R, Westwood M, Wong K, Rothman MT, Shipolini A, Smith EJ, Mills PG, Timmis AD, Knight CJ, Archbold RA, Wragg A. Clinical outcomes after myocardial revascularization according to operator training status: cohort study of 22,697 patients undergoing percutaneous coronary intervention or coronary artery bypass graft surgery. Eur Heart J. 2013 Oct;34(37):2887-95. doi: 10.1093/eurheartj/eht161.

21. Efros LA, Lukin OP, Samorodskaya IV, Semenov VYu, Sumin AN, Ivanov SV, Evseeva MV, Barbarash OL. Comorbidities in patients with coronary Complex Issues of Cardiovascular Diseases. 2017;6(4):71-79. (In Russ.) https://doi.org/10.17802/2306-1278-2017-6-4-71-79

22. Barbarash N.L., Semjonov V.Yu., Samorodskaya I.V., Evseeva М.V., Rozhkov N.A., Sumin A.N., Barbarash L.S. Comorbidity in coronary heart disease patients undergoing bypass grafting: an experience of two surgery centers. Russian Journal of Cardiology. 2017;(3):6-13. (In Russ.) https://doi.org/10.15829/1560-4071-2017-3-6-13

23.